By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > What condition is Ingrezza used to treat?

What condition is Ingrezza used to treat?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023

Key Points

  • Ingrezza (valbenazine) capsules are approved for the treatment of adults with tardive dyskinesia. Tardive dyskinesia (TD) is characterized by abnormal and repetitive movements of the trunk, extremities or face.
  • Tardive dyskinesia is caused by dopamine blockade in the brain which can occur with longer-term antipsychotic treatment. Dopamine is a chemical neurotransmitter.
  • Ingrezza, a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor, was the first product approved for adults with TD.

When should you take Ingrezza for tardive dyskinesia?

Ingrezza is a once daily oral medicine you take by mouth. Ingrezza comes as a 40 mg and 80 mg capsule. It can be taken with or without food. Take Ingrezza exactly when your doctor tells you to take it.

Your doctor will tell you how much Ingrezza to take and when to take it. Do not stop taking this medicine without first speaking to your doctor.

It is not known if Ingrezza is safe and effective for use in children.

Related: Ingrezza dosing (in more detail)

Is Ingrezza an antipsychotic agent?

No, Ingrezza is not an antipsychotic agent. It is a VMAT2 inhibitor (vesicular monoamine transporter-2 inhibitor). It works by blocking VMAT2 to slow the uptake of a brain chemical known as dopamine. This helps to reduce the unwanted body movements of tardive dyskinesia (TD) caused by long-term use of antipsychotics.

TD can cause repetitive movements in your body that you cannot control. These areas can include your arms, hands, legs, feet, face, lips, eyes or tongue. The face is the most common area where these uncontrollable movements occur.

Antipsychotics medicines are often use to treat bipolar disorder, depression or schizophrenia. Ingrezza is used to treat certain movement disorder side effects that may occur if you have been using antipsychotics for at least 3 months.

This is not all the information you need to know about Ingrezza (valbenazine) for safe and effective use. Review the full Ingrezza information here, and discuss this information and any questions you have with your doctor or other health care provider.

Share this Article

Featured questions

  • Austedo vs Ingrezza: How do they compare?
  • How long does it take for Ingrezza to work?
  • How effective is Ingrezza?
  • Ingrezza mechanism of action: How does it work?
  • Can Ingrezza capsules be opened?
  • How much does Ingrezza cost?
  • Does Ingrezza cause weight gain?
  • Which pharmacies can dispense Ingrezza?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by